BerganKDV Wealth Management’s Journey Medical DERM Stock Holding History

BerganKDV Wealth Management’s Portfolio DERM Stock Details DERM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$3.18K	Buy	+2,000	New	+$3.22K	﹤0.01%	648

Other funds holding DERM

BRF

B. Riley Financial Los Angeles, California $456M AUM 896.07% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

AFG

American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BJL

Brighton Jones LLC Seattle, Washington $2.37B AUM 16.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BRWA

B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return

BerganKDV Wealth Management's DERM Position: Q2 2023 in Review

BerganKDV Wealth Management opened a new position in Journey Medical (DERM) in Q2 2023: 2,000 shares worth $3.18K. The stake represents ﹤0.01% of the portfolio and ranks #648 among its holdings.

20 funds tracked by Wall St. Rank hold DERM as of Q2 2023.

BerganKDV Wealth Management held 2,000 shares of Journey Medical worth $3.18K as of Q2 2023.
Journey Medical was a new BerganKDV Wealth Management position in Q2 2023.
Journey Medical made up ﹤0.01% of BerganKDV Wealth Management's portfolio in Q2 2023, its #648 holding.
20 funds tracked by Wall St. Rank held Journey Medical as of Q2 2023.

Based on BerganKDV Wealth Management's 13F filing for Q2 2023, filed 24 Jul 2023.